Global Production-grade Biopharmaceutical Equipment Supply, Demand and Key Producers, 2026-2032
The global Production-grade Biopharmaceutical Equipment market size is expected to reach $ 22035 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032).
In the biopharmaceutical field, the equipment configuration is most complete and the process requirements are most stringent during the large-scale production stage. Manufacturing activities in this industry typically revolve around 'cell or microbial amplification?product expression?harvesting and clarification?purification and refining?concentration and fluid exchange?aseptic assurance and formulation,' with production organization exhibiting significant high cleanliness, high consistency, and strong validation attributes. From the perspective of equipment placement, bioreactors, single-use bioreactors, fermenters, and storage systems primarily undertake cell culture or virus amplification tasks in the production of antibody drugs, recombinant protein drugs, and vaccine bulk solutions; depth filtration, centrifuges, TFF systems, chromatography systems, and sterile filtration constitute the main body of downstream purification, used for cell removal, target protein capture, virus removal, concentration, and buffer replacement; and solution preparation systems, online solution preparation, and CIP cleaning systems serve the preparation of culture media, buffers, and formulation solutions, and undertake batch-to-batch switching and validation cleaning tasks. For cell therapy products such as CAR-T, although the overall production volume is smaller than that of monoclonal antibodies, they rely more heavily on closed fluid pathways, aseptic connections, and automated cell processing platforms. For small nucleic acid drugs, the purification and medium-change processes are more sensitive to membrane systems and chromatography platforms. Overall, in the biopharmaceutical field, equipment used in large-scale production and purification stages not only performs manufacturing functions but also serves as the underlying support for drug quality consistency, regulatory compliance, and commercial scale-up.
Changes in the policy environment often create new growth opportunities for industries. Currently, major global economies are placing biomanufacturing on their strategic agendas, and a series of favorable policies are significantly expanding the market space for biomanufacturing equipment. For example, after the outbreak of the pandemic, countries realized the importance of domestic biopharmaceutical production capacity, and governments led or supported the construction of vaccine and biopharmaceutical factories, directly driving large-scale procurement of related equipment. The United States, through legislation such as the National Biomanufacturing Initiative and the CHIPS and Science Act, has invested billions of dollars to strengthen its domestic biotechnology supply chain, not only encouraging companies to increase R&D, but also using some funds directly to purchase key equipment such as advanced bioreactors and aseptic filling equipment. China has introduced industrial policies to support the localization of high-end biopharmaceutical equipment, providing preferential treatment in terms of funding, land use, and taxation, enabling domestic equipment manufacturers to accelerate their growth under the favorable policy environment. For equipment companies, actively positioning themselves in line with these policy directions can fully share in the policy dividends.
The continued high-speed growth of the pharmaceutical sector is paramount: In recent years, the proportion of biopharmaceuticals in the global pharmaceutical market has been continuously increasing, and multiple new therapy pipelines have entered the commercialization stage, generating a large demand for new production capacity. The global market for biopharmaceutical process equipment and consumables is experiencing rapid growth. This rapid growth directly reflects the strong demand for equipment driven by the expansion of downstream biopharmaceutical production capacity. In the coming years, a large number of new antibody drug, vaccine, and gene therapy production lines will be built and put into operation, leading to a steady increase in orders for various fermenters, cell culture systems, and purification equipment. For equipment suppliers, this is the most crucial and sustainable market driver.
This report studies the global Production-grade Biopharmaceutical Equipment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Production-grade Biopharmaceutical Equipment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Production-grade Biopharmaceutical Equipment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Production-grade Biopharmaceutical Equipment total market, 2021-2032, (USD Million)
Global Production-grade Biopharmaceutical Equipment total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Production-grade Biopharmaceutical Equipment total market, key domestic companies, and share, (USD Million)
Global Production-grade Biopharmaceutical Equipment revenue by player, revenue and market share 2021-2026, (USD Million)
Global Production-grade Biopharmaceutical Equipment total market by Type, CAGR, 2021-2032, (USD Million)
Global Production-grade Biopharmaceutical Equipment total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Production-grade Biopharmaceutical Equipment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Sartorius, Merck KGaA, GEA, ALFA LAVAL, Morimatsu Industry, Sulzer Ltd, Tofflon, SPX Flow, Lisure Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Production-grade Biopharmaceutical Equipment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Production-grade Biopharmaceutical Equipment Market, By Region:
1. How big is the global Production-grade Biopharmaceutical Equipment market?
2. What is the demand of the global Production-grade Biopharmaceutical Equipment market?
3. What is the year over year growth of the global Production-grade Biopharmaceutical Equipment market?
4. What is the total value of the global Production-grade Biopharmaceutical Equipment market?
5. Who are the Major Players in the global Production-grade Biopharmaceutical Equipment market?
6. What are the growth factors driving the market demand?
In the biopharmaceutical field, the equipment configuration is most complete and the process requirements are most stringent during the large-scale production stage. Manufacturing activities in this industry typically revolve around 'cell or microbial amplification?product expression?harvesting and clarification?purification and refining?concentration and fluid exchange?aseptic assurance and formulation,' with production organization exhibiting significant high cleanliness, high consistency, and strong validation attributes. From the perspective of equipment placement, bioreactors, single-use bioreactors, fermenters, and storage systems primarily undertake cell culture or virus amplification tasks in the production of antibody drugs, recombinant protein drugs, and vaccine bulk solutions; depth filtration, centrifuges, TFF systems, chromatography systems, and sterile filtration constitute the main body of downstream purification, used for cell removal, target protein capture, virus removal, concentration, and buffer replacement; and solution preparation systems, online solution preparation, and CIP cleaning systems serve the preparation of culture media, buffers, and formulation solutions, and undertake batch-to-batch switching and validation cleaning tasks. For cell therapy products such as CAR-T, although the overall production volume is smaller than that of monoclonal antibodies, they rely more heavily on closed fluid pathways, aseptic connections, and automated cell processing platforms. For small nucleic acid drugs, the purification and medium-change processes are more sensitive to membrane systems and chromatography platforms. Overall, in the biopharmaceutical field, equipment used in large-scale production and purification stages not only performs manufacturing functions but also serves as the underlying support for drug quality consistency, regulatory compliance, and commercial scale-up.
Changes in the policy environment often create new growth opportunities for industries. Currently, major global economies are placing biomanufacturing on their strategic agendas, and a series of favorable policies are significantly expanding the market space for biomanufacturing equipment. For example, after the outbreak of the pandemic, countries realized the importance of domestic biopharmaceutical production capacity, and governments led or supported the construction of vaccine and biopharmaceutical factories, directly driving large-scale procurement of related equipment. The United States, through legislation such as the National Biomanufacturing Initiative and the CHIPS and Science Act, has invested billions of dollars to strengthen its domestic biotechnology supply chain, not only encouraging companies to increase R&D, but also using some funds directly to purchase key equipment such as advanced bioreactors and aseptic filling equipment. China has introduced industrial policies to support the localization of high-end biopharmaceutical equipment, providing preferential treatment in terms of funding, land use, and taxation, enabling domestic equipment manufacturers to accelerate their growth under the favorable policy environment. For equipment companies, actively positioning themselves in line with these policy directions can fully share in the policy dividends.
The continued high-speed growth of the pharmaceutical sector is paramount: In recent years, the proportion of biopharmaceuticals in the global pharmaceutical market has been continuously increasing, and multiple new therapy pipelines have entered the commercialization stage, generating a large demand for new production capacity. The global market for biopharmaceutical process equipment and consumables is experiencing rapid growth. This rapid growth directly reflects the strong demand for equipment driven by the expansion of downstream biopharmaceutical production capacity. In the coming years, a large number of new antibody drug, vaccine, and gene therapy production lines will be built and put into operation, leading to a steady increase in orders for various fermenters, cell culture systems, and purification equipment. For equipment suppliers, this is the most crucial and sustainable market driver.
This report studies the global Production-grade Biopharmaceutical Equipment demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Production-grade Biopharmaceutical Equipment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Production-grade Biopharmaceutical Equipment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Production-grade Biopharmaceutical Equipment total market, 2021-2032, (USD Million)
Global Production-grade Biopharmaceutical Equipment total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Production-grade Biopharmaceutical Equipment total market, key domestic companies, and share, (USD Million)
Global Production-grade Biopharmaceutical Equipment revenue by player, revenue and market share 2021-2026, (USD Million)
Global Production-grade Biopharmaceutical Equipment total market by Type, CAGR, 2021-2032, (USD Million)
Global Production-grade Biopharmaceutical Equipment total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Production-grade Biopharmaceutical Equipment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danaher, Sartorius, Merck KGaA, GEA, ALFA LAVAL, Morimatsu Industry, Sulzer Ltd, Tofflon, SPX Flow, Lisure Science, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Production-grade Biopharmaceutical Equipment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Production-grade Biopharmaceutical Equipment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Raw Material Handling and Preparation Equipment
- Material Conveying Equipment
- Air Supply Engineering Equipment
- Bioreactors and Fermenters
- Separation and Purification Equipment
- Evaporation and Crystallization Equipment
- Drying Equipment
- Cleaning Equipment
- Others
- Based on Single-use Process
- Based on Reusable Process
- ?2000L
- 2000-5000L
- ?5000L
- Macromolecular Biopharmaceuticals
- Small Molecule Chemical Drugs
- Danaher
- Sartorius
- Merck KGaA
- GEA
- ALFA LAVAL
- Morimatsu Industry
- Sulzer Ltd
- Tofflon
- SPX Flow
- Lisure Science
- AUSTAR Group
- Truking Technology
- Pierre Guerin
- EastBio
- Krones AG
- ABEC
- Flottweg SE
- Tomoe
- Jiangsu Zhengchang Group
- DCI, Inc.
- Greatwall Mixers
- EKATO
- Jiangsu Hanbon
- Cotter Brothers Corporation
- Holloway America
- BHS-Sonthofen GmbH
- Actini Group
- Shanghai Triowin Intelligent Machinery
- YMC CO., LTD.
- Ohkawara Kakohki Co., Ltd.
- Suntar Environmental Technology
- Buss-SMS-Canzler GmbH
- TECNIC
- Jiangsu Jiuwu Hi-Tech
- Hengfengtai
- Beijing ChuangXinTongHeng
- BIIC Bianchi SpA
- Alsys Group
- Solaris Biotech
1. How big is the global Production-grade Biopharmaceutical Equipment market?
2. What is the demand of the global Production-grade Biopharmaceutical Equipment market?
3. What is the year over year growth of the global Production-grade Biopharmaceutical Equipment market?
4. What is the total value of the global Production-grade Biopharmaceutical Equipment market?
5. Who are the Major Players in the global Production-grade Biopharmaceutical Equipment market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Production-grade Biopharmaceutical Equipment Introduction
1.2 World Production-grade Biopharmaceutical Equipment Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Production-grade Biopharmaceutical Equipment Total Market by Region (by Headquarter Location)
1.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.3 China Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.4 Europe Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.5 Japan Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.6 South Korea Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.7 ASEAN Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.8 India Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Production-grade Biopharmaceutical Equipment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.2 World Production-grade Biopharmaceutical Equipment Consumption Value by Region
2.2.1 World Production-grade Biopharmaceutical Equipment Consumption Value by Region (2021-2026)
2.2.2 World Production-grade Biopharmaceutical Equipment Consumption Value Forecast by Region (2027-2032)
2.3 United States Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.4 China Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.5 Europe Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.6 Japan Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.7 South Korea Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.8 ASEAN Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.9 India Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
3 WORLD PRODUCTION-GRADE BIOPHARMACEUTICAL EQUIPMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Production-grade Biopharmaceutical Equipment Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Production-grade Biopharmaceutical Equipment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Production-grade Biopharmaceutical Equipment in 2025
3.2.3 Global Concentration Ratios (CR8) for Production-grade Biopharmaceutical Equipment in 2025
3.3 Production-grade Biopharmaceutical Equipment Company Evaluation Quadrant
3.4 Production-grade Biopharmaceutical Equipment Market: Overall Company Footprint Analysis
3.4.1 Production-grade Biopharmaceutical Equipment Market: Region Footprint
3.4.2 Production-grade Biopharmaceutical Equipment Market: Company Product Type Footprint
3.4.3 Production-grade Biopharmaceutical Equipment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Production-grade Biopharmaceutical Equipment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Production-grade Biopharmaceutical Equipment Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Production-grade Biopharmaceutical Equipment Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Production-grade Biopharmaceutical Equipment Consumption Value Comparison
4.2.1 United States VS China: Production-grade Biopharmaceutical Equipment Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Production-grade Biopharmaceutical Equipment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Production-grade Biopharmaceutical Equipment Companies and Market Share, 2021-2026
4.3.1 United States Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026)
4.4 China Based Companies Production-grade Biopharmaceutical Equipment Revenue and Market Share, 2021-2026
4.4.1 China Based Production-grade Biopharmaceutical Equipment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026)
4.5 Rest of World Based Production-grade Biopharmaceutical Equipment Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Production-grade Biopharmaceutical Equipment Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Raw Material Handling and Preparation Equipment
5.2.2 Material Conveying Equipment
5.2.3 Air Supply Engineering Equipment
5.2.4 Bioreactors and Fermenters
5.2.5 Separation and Purification Equipment
5.2.6 Evaporation and Crystallization Equipment
5.2.7 Drying Equipment
5.2.8 Cleaning Equipment
5.2.9 Others
5.3 Market Segment by Type
5.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Type (2021-2026)
5.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Type (2027-2032)
5.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PROCESS
6.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Process: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Process
6.2.1 Based on Single-use Process
6.2.2 Based on Reusable Process
6.3 Market Segment by Process
6.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Process (2021-2026)
6.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Process (2027-2032)
6.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Process (2027-2032)
7 MARKET ANALYSIS BY BIO-FERMENTATION CAPACITY
7.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Bio-fermentation Capacity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Bio-fermentation Capacity
7.2.1 ?2000L
7.2.2 2000-5000L
7.2.3 ?5000L
7.3 Market Segment by Bio-fermentation Capacity
7.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity (2021-2026)
7.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity (2027-2032)
7.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Bio-fermentation Capacity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Macromolecular Biopharmaceuticals
8.2.2 Small Molecule Chemical Drugs
8.3 Market Segment by Application
8.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Application (2021-2026)
8.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Application (2027-2032)
8.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Danaher
9.1.1 Danaher Details
9.1.2 Danaher Major Business
9.1.3 Danaher Production-grade Biopharmaceutical Equipment Product and Services
9.1.4 Danaher Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Danaher Recent Developments/Updates
9.1.6 Danaher Competitive Strengths & Weaknesses
9.2 Sartorius
9.2.1 Sartorius Details
9.2.2 Sartorius Major Business
9.2.3 Sartorius Production-grade Biopharmaceutical Equipment Product and Services
9.2.4 Sartorius Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sartorius Recent Developments/Updates
9.2.6 Sartorius Competitive Strengths & Weaknesses
9.3 Merck KGaA
9.3.1 Merck KGaA Details
9.3.2 Merck KGaA Major Business
9.3.3 Merck KGaA Production-grade Biopharmaceutical Equipment Product and Services
9.3.4 Merck KGaA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck KGaA Recent Developments/Updates
9.3.6 Merck KGaA Competitive Strengths & Weaknesses
9.4 GEA
9.4.1 GEA Details
9.4.2 GEA Major Business
9.4.3 GEA Production-grade Biopharmaceutical Equipment Product and Services
9.4.4 GEA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 GEA Recent Developments/Updates
9.4.6 GEA Competitive Strengths & Weaknesses
9.5 ALFA LAVAL
9.5.1 ALFA LAVAL Details
9.5.2 ALFA LAVAL Major Business
9.5.3 ALFA LAVAL Production-grade Biopharmaceutical Equipment Product and Services
9.5.4 ALFA LAVAL Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 ALFA LAVAL Recent Developments/Updates
9.5.6 ALFA LAVAL Competitive Strengths & Weaknesses
9.6 Morimatsu Industry
9.6.1 Morimatsu Industry Details
9.6.2 Morimatsu Industry Major Business
9.6.3 Morimatsu Industry Production-grade Biopharmaceutical Equipment Product and Services
9.6.4 Morimatsu Industry Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Morimatsu Industry Recent Developments/Updates
9.6.6 Morimatsu Industry Competitive Strengths & Weaknesses
9.7 Sulzer Ltd
9.7.1 Sulzer Ltd Details
9.7.2 Sulzer Ltd Major Business
9.7.3 Sulzer Ltd Production-grade Biopharmaceutical Equipment Product and Services
9.7.4 Sulzer Ltd Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sulzer Ltd Recent Developments/Updates
9.7.6 Sulzer Ltd Competitive Strengths & Weaknesses
9.8 Tofflon
9.8.1 Tofflon Details
9.8.2 Tofflon Major Business
9.8.3 Tofflon Production-grade Biopharmaceutical Equipment Product and Services
9.8.4 Tofflon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Tofflon Recent Developments/Updates
9.8.6 Tofflon Competitive Strengths & Weaknesses
9.9 SPX Flow
9.9.1 SPX Flow Details
9.9.2 SPX Flow Major Business
9.9.3 SPX Flow Production-grade Biopharmaceutical Equipment Product and Services
9.9.4 SPX Flow Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SPX Flow Recent Developments/Updates
9.9.6 SPX Flow Competitive Strengths & Weaknesses
9.10 Lisure Science
9.10.1 Lisure Science Details
9.10.2 Lisure Science Major Business
9.10.3 Lisure Science Production-grade Biopharmaceutical Equipment Product and Services
9.10.4 Lisure Science Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Lisure Science Recent Developments/Updates
9.10.6 Lisure Science Competitive Strengths & Weaknesses
9.11 AUSTAR Group
9.11.1 AUSTAR Group Details
9.11.2 AUSTAR Group Major Business
9.11.3 AUSTAR Group Production-grade Biopharmaceutical Equipment Product and Services
9.11.4 AUSTAR Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 AUSTAR Group Recent Developments/Updates
9.11.6 AUSTAR Group Competitive Strengths & Weaknesses
9.12 Truking Technology
9.12.1 Truking Technology Details
9.12.2 Truking Technology Major Business
9.12.3 Truking Technology Production-grade Biopharmaceutical Equipment Product and Services
9.12.4 Truking Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Truking Technology Recent Developments/Updates
9.12.6 Truking Technology Competitive Strengths & Weaknesses
9.13 Pierre Guerin
9.13.1 Pierre Guerin Details
9.13.2 Pierre Guerin Major Business
9.13.3 Pierre Guerin Production-grade Biopharmaceutical Equipment Product and Services
9.13.4 Pierre Guerin Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Pierre Guerin Recent Developments/Updates
9.13.6 Pierre Guerin Competitive Strengths & Weaknesses
9.14 EastBio
9.14.1 EastBio Details
9.14.2 EastBio Major Business
9.14.3 EastBio Production-grade Biopharmaceutical Equipment Product and Services
9.14.4 EastBio Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 EastBio Recent Developments/Updates
9.14.6 EastBio Competitive Strengths & Weaknesses
9.15 Krones AG
9.15.1 Krones AG Details
9.15.2 Krones AG Major Business
9.15.3 Krones AG Production-grade Biopharmaceutical Equipment Product and Services
9.15.4 Krones AG Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Krones AG Recent Developments/Updates
9.15.6 Krones AG Competitive Strengths & Weaknesses
9.16 ABEC
9.16.1 ABEC Details
9.16.2 ABEC Major Business
9.16.3 ABEC Production-grade Biopharmaceutical Equipment Product and Services
9.16.4 ABEC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 ABEC Recent Developments/Updates
9.16.6 ABEC Competitive Strengths & Weaknesses
9.17 Flottweg SE
9.17.1 Flottweg SE Details
9.17.2 Flottweg SE Major Business
9.17.3 Flottweg SE Production-grade Biopharmaceutical Equipment Product and Services
9.17.4 Flottweg SE Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Flottweg SE Recent Developments/Updates
9.17.6 Flottweg SE Competitive Strengths & Weaknesses
9.18 Tomoe
9.18.1 Tomoe Details
9.18.2 Tomoe Major Business
9.18.3 Tomoe Production-grade Biopharmaceutical Equipment Product and Services
9.18.4 Tomoe Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Tomoe Recent Developments/Updates
9.18.6 Tomoe Competitive Strengths & Weaknesses
9.19 Jiangsu Zhengchang Group
9.19.1 Jiangsu Zhengchang Group Details
9.19.2 Jiangsu Zhengchang Group Major Business
9.19.3 Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Product and Services
9.19.4 Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Jiangsu Zhengchang Group Recent Developments/Updates
9.19.6 Jiangsu Zhengchang Group Competitive Strengths & Weaknesses
9.20 DCI, Inc.
9.20.1 DCI, Inc. Details
9.20.2 DCI, Inc. Major Business
9.20.3 DCI, Inc. Production-grade Biopharmaceutical Equipment Product and Services
9.20.4 DCI, Inc. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 DCI, Inc. Recent Developments/Updates
9.20.6 DCI, Inc. Competitive Strengths & Weaknesses
9.21 Greatwall Mixers
9.21.1 Greatwall Mixers Details
9.21.2 Greatwall Mixers Major Business
9.21.3 Greatwall Mixers Production-grade Biopharmaceutical Equipment Product and Services
9.21.4 Greatwall Mixers Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Greatwall Mixers Recent Developments/Updates
9.21.6 Greatwall Mixers Competitive Strengths & Weaknesses
9.22 EKATO
9.22.1 EKATO Details
9.22.2 EKATO Major Business
9.22.3 EKATO Production-grade Biopharmaceutical Equipment Product and Services
9.22.4 EKATO Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 EKATO Recent Developments/Updates
9.22.6 EKATO Competitive Strengths & Weaknesses
9.23 Jiangsu Hanbon
9.23.1 Jiangsu Hanbon Details
9.23.2 Jiangsu Hanbon Major Business
9.23.3 Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Product and Services
9.23.4 Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Jiangsu Hanbon Recent Developments/Updates
9.23.6 Jiangsu Hanbon Competitive Strengths & Weaknesses
9.24 Cotter Brothers Corporation
9.24.1 Cotter Brothers Corporation Details
9.24.2 Cotter Brothers Corporation Major Business
9.24.3 Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Product and Services
9.24.4 Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Cotter Brothers Corporation Recent Developments/Updates
9.24.6 Cotter Brothers Corporation Competitive Strengths & Weaknesses
9.25 Holloway America
9.25.1 Holloway America Details
9.25.2 Holloway America Major Business
9.25.3 Holloway America Production-grade Biopharmaceutical Equipment Product and Services
9.25.4 Holloway America Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Holloway America Recent Developments/Updates
9.25.6 Holloway America Competitive Strengths & Weaknesses
9.26 BHS-Sonthofen GmbH
9.26.1 BHS-Sonthofen GmbH Details
9.26.2 BHS-Sonthofen GmbH Major Business
9.26.3 BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Product and Services
9.26.4 BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 BHS-Sonthofen GmbH Recent Developments/Updates
9.26.6 BHS-Sonthofen GmbH Competitive Strengths & Weaknesses
9.27 Actini Group
9.27.1 Actini Group Details
9.27.2 Actini Group Major Business
9.27.3 Actini Group Production-grade Biopharmaceutical Equipment Product and Services
9.27.4 Actini Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Actini Group Recent Developments/Updates
9.27.6 Actini Group Competitive Strengths & Weaknesses
9.28 Shanghai Triowin Intelligent Machinery
9.28.1 Shanghai Triowin Intelligent Machinery Details
9.28.2 Shanghai Triowin Intelligent Machinery Major Business
9.28.3 Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Product and Services
9.28.4 Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Shanghai Triowin Intelligent Machinery Recent Developments/Updates
9.28.6 Shanghai Triowin Intelligent Machinery Competitive Strengths & Weaknesses
9.29 YMC CO., LTD.
9.29.1 YMC CO., LTD. Details
9.29.2 YMC CO., LTD. Major Business
9.29.3 YMC CO., LTD. Production-grade Biopharmaceutical Equipment Product and Services
9.29.4 YMC CO., LTD. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 YMC CO., LTD. Recent Developments/Updates
9.29.6 YMC CO., LTD. Competitive Strengths & Weaknesses
9.30 Ohkawara Kakohki Co., Ltd.
9.30.1 Ohkawara Kakohki Co., Ltd. Details
9.30.2 Ohkawara Kakohki Co., Ltd. Major Business
9.30.3 Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Product and Services
9.30.4 Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Ohkawara Kakohki Co., Ltd. Recent Developments/Updates
9.30.6 Ohkawara Kakohki Co., Ltd. Competitive Strengths & Weaknesses
9.31 Suntar Environmental Technology
9.31.1 Suntar Environmental Technology Details
9.31.2 Suntar Environmental Technology Major Business
9.31.3 Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Product and Services
9.31.4 Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Suntar Environmental Technology Recent Developments/Updates
9.31.6 Suntar Environmental Technology Competitive Strengths & Weaknesses
9.32 Buss-SMS-Canzler GmbH
9.32.1 Buss-SMS-Canzler GmbH Details
9.32.2 Buss-SMS-Canzler GmbH Major Business
9.32.3 Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Product and Services
9.32.4 Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Buss-SMS-Canzler GmbH Recent Developments/Updates
9.32.6 Buss-SMS-Canzler GmbH Competitive Strengths & Weaknesses
9.33 TECNIC
9.33.1 TECNIC Details
9.33.2 TECNIC Major Business
9.33.3 TECNIC Production-grade Biopharmaceutical Equipment Product and Services
9.33.4 TECNIC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 TECNIC Recent Developments/Updates
9.33.6 TECNIC Competitive Strengths & Weaknesses
9.34 Jiangsu Jiuwu Hi-Tech
9.34.1 Jiangsu Jiuwu Hi-Tech Details
9.34.2 Jiangsu Jiuwu Hi-Tech Major Business
9.34.3 Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Product and Services
9.34.4 Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Jiangsu Jiuwu Hi-Tech Recent Developments/Updates
9.34.6 Jiangsu Jiuwu Hi-Tech Competitive Strengths & Weaknesses
9.35 Hengfengtai
9.35.1 Hengfengtai Details
9.35.2 Hengfengtai Major Business
9.35.3 Hengfengtai Production-grade Biopharmaceutical Equipment Product and Services
9.35.4 Hengfengtai Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Hengfengtai Recent Developments/Updates
9.35.6 Hengfengtai Competitive Strengths & Weaknesses
9.36 Beijing ChuangXinTongHeng
9.36.1 Beijing ChuangXinTongHeng Details
9.36.2 Beijing ChuangXinTongHeng Major Business
9.36.3 Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Product and Services
9.36.4 Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Beijing ChuangXinTongHeng Recent Developments/Updates
9.36.6 Beijing ChuangXinTongHeng Competitive Strengths & Weaknesses
9.37 BIIC Bianchi SpA
9.37.1 BIIC Bianchi SpA Details
9.37.2 BIIC Bianchi SpA Major Business
9.37.3 BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Product and Services
9.37.4 BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 BIIC Bianchi SpA Recent Developments/Updates
9.37.6 BIIC Bianchi SpA Competitive Strengths & Weaknesses
9.38 Alsys Group
9.38.1 Alsys Group Details
9.38.2 Alsys Group Major Business
9.38.3 Alsys Group Production-grade Biopharmaceutical Equipment Product and Services
9.38.4 Alsys Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Alsys Group Recent Developments/Updates
9.38.6 Alsys Group Competitive Strengths & Weaknesses
9.39 Solaris Biotech
9.39.1 Solaris Biotech Details
9.39.2 Solaris Biotech Major Business
9.39.3 Solaris Biotech Production-grade Biopharmaceutical Equipment Product and Services
9.39.4 Solaris Biotech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Solaris Biotech Recent Developments/Updates
9.39.6 Solaris Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Production-grade Biopharmaceutical Equipment Industry Chain
10.2 Production-grade Biopharmaceutical Equipment Upstream Analysis
10.3 Production-grade Biopharmaceutical Equipment Midstream Analysis
10.4 Production-grade Biopharmaceutical Equipment Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Production-grade Biopharmaceutical Equipment Introduction
1.2 World Production-grade Biopharmaceutical Equipment Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Production-grade Biopharmaceutical Equipment Total Market by Region (by Headquarter Location)
1.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.3 China Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.4 Europe Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.5 Japan Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.6 South Korea Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.7 ASEAN Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.3.8 India Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Production-grade Biopharmaceutical Equipment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.2 World Production-grade Biopharmaceutical Equipment Consumption Value by Region
2.2.1 World Production-grade Biopharmaceutical Equipment Consumption Value by Region (2021-2026)
2.2.2 World Production-grade Biopharmaceutical Equipment Consumption Value Forecast by Region (2027-2032)
2.3 United States Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.4 China Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.5 Europe Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.6 Japan Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.7 South Korea Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.8 ASEAN Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
2.9 India Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032)
3 WORLD PRODUCTION-GRADE BIOPHARMACEUTICAL EQUIPMENT COMPANIES COMPETITIVE ANALYSIS
3.1 World Production-grade Biopharmaceutical Equipment Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Production-grade Biopharmaceutical Equipment Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Production-grade Biopharmaceutical Equipment in 2025
3.2.3 Global Concentration Ratios (CR8) for Production-grade Biopharmaceutical Equipment in 2025
3.3 Production-grade Biopharmaceutical Equipment Company Evaluation Quadrant
3.4 Production-grade Biopharmaceutical Equipment Market: Overall Company Footprint Analysis
3.4.1 Production-grade Biopharmaceutical Equipment Market: Region Footprint
3.4.2 Production-grade Biopharmaceutical Equipment Market: Company Product Type Footprint
3.4.3 Production-grade Biopharmaceutical Equipment Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Production-grade Biopharmaceutical Equipment Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Production-grade Biopharmaceutical Equipment Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Production-grade Biopharmaceutical Equipment Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Production-grade Biopharmaceutical Equipment Consumption Value Comparison
4.2.1 United States VS China: Production-grade Biopharmaceutical Equipment Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Production-grade Biopharmaceutical Equipment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Production-grade Biopharmaceutical Equipment Companies and Market Share, 2021-2026
4.3.1 United States Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026)
4.4 China Based Companies Production-grade Biopharmaceutical Equipment Revenue and Market Share, 2021-2026
4.4.1 China Based Production-grade Biopharmaceutical Equipment Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026)
4.5 Rest of World Based Production-grade Biopharmaceutical Equipment Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Production-grade Biopharmaceutical Equipment Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Raw Material Handling and Preparation Equipment
5.2.2 Material Conveying Equipment
5.2.3 Air Supply Engineering Equipment
5.2.4 Bioreactors and Fermenters
5.2.5 Separation and Purification Equipment
5.2.6 Evaporation and Crystallization Equipment
5.2.7 Drying Equipment
5.2.8 Cleaning Equipment
5.2.9 Others
5.3 Market Segment by Type
5.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Type (2021-2026)
5.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Type (2027-2032)
5.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PROCESS
6.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Process: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Process
6.2.1 Based on Single-use Process
6.2.2 Based on Reusable Process
6.3 Market Segment by Process
6.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Process (2021-2026)
6.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Process (2027-2032)
6.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Process (2027-2032)
7 MARKET ANALYSIS BY BIO-FERMENTATION CAPACITY
7.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Bio-fermentation Capacity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Bio-fermentation Capacity
7.2.1 ?2000L
7.2.2 2000-5000L
7.2.3 ?5000L
7.3 Market Segment by Bio-fermentation Capacity
7.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity (2021-2026)
7.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity (2027-2032)
7.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Bio-fermentation Capacity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Production-grade Biopharmaceutical Equipment Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Macromolecular Biopharmaceuticals
8.2.2 Small Molecule Chemical Drugs
8.3 Market Segment by Application
8.3.1 World Production-grade Biopharmaceutical Equipment Market Size by Application (2021-2026)
8.3.2 World Production-grade Biopharmaceutical Equipment Market Size by Application (2027-2032)
8.3.3 World Production-grade Biopharmaceutical Equipment Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Danaher
9.1.1 Danaher Details
9.1.2 Danaher Major Business
9.1.3 Danaher Production-grade Biopharmaceutical Equipment Product and Services
9.1.4 Danaher Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Danaher Recent Developments/Updates
9.1.6 Danaher Competitive Strengths & Weaknesses
9.2 Sartorius
9.2.1 Sartorius Details
9.2.2 Sartorius Major Business
9.2.3 Sartorius Production-grade Biopharmaceutical Equipment Product and Services
9.2.4 Sartorius Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Sartorius Recent Developments/Updates
9.2.6 Sartorius Competitive Strengths & Weaknesses
9.3 Merck KGaA
9.3.1 Merck KGaA Details
9.3.2 Merck KGaA Major Business
9.3.3 Merck KGaA Production-grade Biopharmaceutical Equipment Product and Services
9.3.4 Merck KGaA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Merck KGaA Recent Developments/Updates
9.3.6 Merck KGaA Competitive Strengths & Weaknesses
9.4 GEA
9.4.1 GEA Details
9.4.2 GEA Major Business
9.4.3 GEA Production-grade Biopharmaceutical Equipment Product and Services
9.4.4 GEA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 GEA Recent Developments/Updates
9.4.6 GEA Competitive Strengths & Weaknesses
9.5 ALFA LAVAL
9.5.1 ALFA LAVAL Details
9.5.2 ALFA LAVAL Major Business
9.5.3 ALFA LAVAL Production-grade Biopharmaceutical Equipment Product and Services
9.5.4 ALFA LAVAL Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 ALFA LAVAL Recent Developments/Updates
9.5.6 ALFA LAVAL Competitive Strengths & Weaknesses
9.6 Morimatsu Industry
9.6.1 Morimatsu Industry Details
9.6.2 Morimatsu Industry Major Business
9.6.3 Morimatsu Industry Production-grade Biopharmaceutical Equipment Product and Services
9.6.4 Morimatsu Industry Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Morimatsu Industry Recent Developments/Updates
9.6.6 Morimatsu Industry Competitive Strengths & Weaknesses
9.7 Sulzer Ltd
9.7.1 Sulzer Ltd Details
9.7.2 Sulzer Ltd Major Business
9.7.3 Sulzer Ltd Production-grade Biopharmaceutical Equipment Product and Services
9.7.4 Sulzer Ltd Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Sulzer Ltd Recent Developments/Updates
9.7.6 Sulzer Ltd Competitive Strengths & Weaknesses
9.8 Tofflon
9.8.1 Tofflon Details
9.8.2 Tofflon Major Business
9.8.3 Tofflon Production-grade Biopharmaceutical Equipment Product and Services
9.8.4 Tofflon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Tofflon Recent Developments/Updates
9.8.6 Tofflon Competitive Strengths & Weaknesses
9.9 SPX Flow
9.9.1 SPX Flow Details
9.9.2 SPX Flow Major Business
9.9.3 SPX Flow Production-grade Biopharmaceutical Equipment Product and Services
9.9.4 SPX Flow Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 SPX Flow Recent Developments/Updates
9.9.6 SPX Flow Competitive Strengths & Weaknesses
9.10 Lisure Science
9.10.1 Lisure Science Details
9.10.2 Lisure Science Major Business
9.10.3 Lisure Science Production-grade Biopharmaceutical Equipment Product and Services
9.10.4 Lisure Science Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Lisure Science Recent Developments/Updates
9.10.6 Lisure Science Competitive Strengths & Weaknesses
9.11 AUSTAR Group
9.11.1 AUSTAR Group Details
9.11.2 AUSTAR Group Major Business
9.11.3 AUSTAR Group Production-grade Biopharmaceutical Equipment Product and Services
9.11.4 AUSTAR Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 AUSTAR Group Recent Developments/Updates
9.11.6 AUSTAR Group Competitive Strengths & Weaknesses
9.12 Truking Technology
9.12.1 Truking Technology Details
9.12.2 Truking Technology Major Business
9.12.3 Truking Technology Production-grade Biopharmaceutical Equipment Product and Services
9.12.4 Truking Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Truking Technology Recent Developments/Updates
9.12.6 Truking Technology Competitive Strengths & Weaknesses
9.13 Pierre Guerin
9.13.1 Pierre Guerin Details
9.13.2 Pierre Guerin Major Business
9.13.3 Pierre Guerin Production-grade Biopharmaceutical Equipment Product and Services
9.13.4 Pierre Guerin Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Pierre Guerin Recent Developments/Updates
9.13.6 Pierre Guerin Competitive Strengths & Weaknesses
9.14 EastBio
9.14.1 EastBio Details
9.14.2 EastBio Major Business
9.14.3 EastBio Production-grade Biopharmaceutical Equipment Product and Services
9.14.4 EastBio Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 EastBio Recent Developments/Updates
9.14.6 EastBio Competitive Strengths & Weaknesses
9.15 Krones AG
9.15.1 Krones AG Details
9.15.2 Krones AG Major Business
9.15.3 Krones AG Production-grade Biopharmaceutical Equipment Product and Services
9.15.4 Krones AG Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Krones AG Recent Developments/Updates
9.15.6 Krones AG Competitive Strengths & Weaknesses
9.16 ABEC
9.16.1 ABEC Details
9.16.2 ABEC Major Business
9.16.3 ABEC Production-grade Biopharmaceutical Equipment Product and Services
9.16.4 ABEC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 ABEC Recent Developments/Updates
9.16.6 ABEC Competitive Strengths & Weaknesses
9.17 Flottweg SE
9.17.1 Flottweg SE Details
9.17.2 Flottweg SE Major Business
9.17.3 Flottweg SE Production-grade Biopharmaceutical Equipment Product and Services
9.17.4 Flottweg SE Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Flottweg SE Recent Developments/Updates
9.17.6 Flottweg SE Competitive Strengths & Weaknesses
9.18 Tomoe
9.18.1 Tomoe Details
9.18.2 Tomoe Major Business
9.18.3 Tomoe Production-grade Biopharmaceutical Equipment Product and Services
9.18.4 Tomoe Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Tomoe Recent Developments/Updates
9.18.6 Tomoe Competitive Strengths & Weaknesses
9.19 Jiangsu Zhengchang Group
9.19.1 Jiangsu Zhengchang Group Details
9.19.2 Jiangsu Zhengchang Group Major Business
9.19.3 Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Product and Services
9.19.4 Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Jiangsu Zhengchang Group Recent Developments/Updates
9.19.6 Jiangsu Zhengchang Group Competitive Strengths & Weaknesses
9.20 DCI, Inc.
9.20.1 DCI, Inc. Details
9.20.2 DCI, Inc. Major Business
9.20.3 DCI, Inc. Production-grade Biopharmaceutical Equipment Product and Services
9.20.4 DCI, Inc. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 DCI, Inc. Recent Developments/Updates
9.20.6 DCI, Inc. Competitive Strengths & Weaknesses
9.21 Greatwall Mixers
9.21.1 Greatwall Mixers Details
9.21.2 Greatwall Mixers Major Business
9.21.3 Greatwall Mixers Production-grade Biopharmaceutical Equipment Product and Services
9.21.4 Greatwall Mixers Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Greatwall Mixers Recent Developments/Updates
9.21.6 Greatwall Mixers Competitive Strengths & Weaknesses
9.22 EKATO
9.22.1 EKATO Details
9.22.2 EKATO Major Business
9.22.3 EKATO Production-grade Biopharmaceutical Equipment Product and Services
9.22.4 EKATO Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 EKATO Recent Developments/Updates
9.22.6 EKATO Competitive Strengths & Weaknesses
9.23 Jiangsu Hanbon
9.23.1 Jiangsu Hanbon Details
9.23.2 Jiangsu Hanbon Major Business
9.23.3 Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Product and Services
9.23.4 Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 Jiangsu Hanbon Recent Developments/Updates
9.23.6 Jiangsu Hanbon Competitive Strengths & Weaknesses
9.24 Cotter Brothers Corporation
9.24.1 Cotter Brothers Corporation Details
9.24.2 Cotter Brothers Corporation Major Business
9.24.3 Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Product and Services
9.24.4 Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 Cotter Brothers Corporation Recent Developments/Updates
9.24.6 Cotter Brothers Corporation Competitive Strengths & Weaknesses
9.25 Holloway America
9.25.1 Holloway America Details
9.25.2 Holloway America Major Business
9.25.3 Holloway America Production-grade Biopharmaceutical Equipment Product and Services
9.25.4 Holloway America Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.25.5 Holloway America Recent Developments/Updates
9.25.6 Holloway America Competitive Strengths & Weaknesses
9.26 BHS-Sonthofen GmbH
9.26.1 BHS-Sonthofen GmbH Details
9.26.2 BHS-Sonthofen GmbH Major Business
9.26.3 BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Product and Services
9.26.4 BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.26.5 BHS-Sonthofen GmbH Recent Developments/Updates
9.26.6 BHS-Sonthofen GmbH Competitive Strengths & Weaknesses
9.27 Actini Group
9.27.1 Actini Group Details
9.27.2 Actini Group Major Business
9.27.3 Actini Group Production-grade Biopharmaceutical Equipment Product and Services
9.27.4 Actini Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.27.5 Actini Group Recent Developments/Updates
9.27.6 Actini Group Competitive Strengths & Weaknesses
9.28 Shanghai Triowin Intelligent Machinery
9.28.1 Shanghai Triowin Intelligent Machinery Details
9.28.2 Shanghai Triowin Intelligent Machinery Major Business
9.28.3 Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Product and Services
9.28.4 Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.28.5 Shanghai Triowin Intelligent Machinery Recent Developments/Updates
9.28.6 Shanghai Triowin Intelligent Machinery Competitive Strengths & Weaknesses
9.29 YMC CO., LTD.
9.29.1 YMC CO., LTD. Details
9.29.2 YMC CO., LTD. Major Business
9.29.3 YMC CO., LTD. Production-grade Biopharmaceutical Equipment Product and Services
9.29.4 YMC CO., LTD. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.29.5 YMC CO., LTD. Recent Developments/Updates
9.29.6 YMC CO., LTD. Competitive Strengths & Weaknesses
9.30 Ohkawara Kakohki Co., Ltd.
9.30.1 Ohkawara Kakohki Co., Ltd. Details
9.30.2 Ohkawara Kakohki Co., Ltd. Major Business
9.30.3 Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Product and Services
9.30.4 Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.30.5 Ohkawara Kakohki Co., Ltd. Recent Developments/Updates
9.30.6 Ohkawara Kakohki Co., Ltd. Competitive Strengths & Weaknesses
9.31 Suntar Environmental Technology
9.31.1 Suntar Environmental Technology Details
9.31.2 Suntar Environmental Technology Major Business
9.31.3 Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Product and Services
9.31.4 Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.31.5 Suntar Environmental Technology Recent Developments/Updates
9.31.6 Suntar Environmental Technology Competitive Strengths & Weaknesses
9.32 Buss-SMS-Canzler GmbH
9.32.1 Buss-SMS-Canzler GmbH Details
9.32.2 Buss-SMS-Canzler GmbH Major Business
9.32.3 Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Product and Services
9.32.4 Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.32.5 Buss-SMS-Canzler GmbH Recent Developments/Updates
9.32.6 Buss-SMS-Canzler GmbH Competitive Strengths & Weaknesses
9.33 TECNIC
9.33.1 TECNIC Details
9.33.2 TECNIC Major Business
9.33.3 TECNIC Production-grade Biopharmaceutical Equipment Product and Services
9.33.4 TECNIC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.33.5 TECNIC Recent Developments/Updates
9.33.6 TECNIC Competitive Strengths & Weaknesses
9.34 Jiangsu Jiuwu Hi-Tech
9.34.1 Jiangsu Jiuwu Hi-Tech Details
9.34.2 Jiangsu Jiuwu Hi-Tech Major Business
9.34.3 Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Product and Services
9.34.4 Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.34.5 Jiangsu Jiuwu Hi-Tech Recent Developments/Updates
9.34.6 Jiangsu Jiuwu Hi-Tech Competitive Strengths & Weaknesses
9.35 Hengfengtai
9.35.1 Hengfengtai Details
9.35.2 Hengfengtai Major Business
9.35.3 Hengfengtai Production-grade Biopharmaceutical Equipment Product and Services
9.35.4 Hengfengtai Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.35.5 Hengfengtai Recent Developments/Updates
9.35.6 Hengfengtai Competitive Strengths & Weaknesses
9.36 Beijing ChuangXinTongHeng
9.36.1 Beijing ChuangXinTongHeng Details
9.36.2 Beijing ChuangXinTongHeng Major Business
9.36.3 Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Product and Services
9.36.4 Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.36.5 Beijing ChuangXinTongHeng Recent Developments/Updates
9.36.6 Beijing ChuangXinTongHeng Competitive Strengths & Weaknesses
9.37 BIIC Bianchi SpA
9.37.1 BIIC Bianchi SpA Details
9.37.2 BIIC Bianchi SpA Major Business
9.37.3 BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Product and Services
9.37.4 BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.37.5 BIIC Bianchi SpA Recent Developments/Updates
9.37.6 BIIC Bianchi SpA Competitive Strengths & Weaknesses
9.38 Alsys Group
9.38.1 Alsys Group Details
9.38.2 Alsys Group Major Business
9.38.3 Alsys Group Production-grade Biopharmaceutical Equipment Product and Services
9.38.4 Alsys Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.38.5 Alsys Group Recent Developments/Updates
9.38.6 Alsys Group Competitive Strengths & Weaknesses
9.39 Solaris Biotech
9.39.1 Solaris Biotech Details
9.39.2 Solaris Biotech Major Business
9.39.3 Solaris Biotech Production-grade Biopharmaceutical Equipment Product and Services
9.39.4 Solaris Biotech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026)
9.39.5 Solaris Biotech Recent Developments/Updates
9.39.6 Solaris Biotech Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Production-grade Biopharmaceutical Equipment Industry Chain
10.2 Production-grade Biopharmaceutical Equipment Upstream Analysis
10.3 Production-grade Biopharmaceutical Equipment Midstream Analysis
10.4 Production-grade Biopharmaceutical Equipment Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Production-grade Biopharmaceutical Equipment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Production-grade Biopharmaceutical Equipment Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Production-grade Biopharmaceutical Equipment Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Production-grade Biopharmaceutical Equipment Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Production-grade Biopharmaceutical Equipment Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Production-grade Biopharmaceutical Equipment Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Production-grade Biopharmaceutical Equipment Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Production-grade Biopharmaceutical Equipment Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Production-grade Biopharmaceutical Equipment Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Production-grade Biopharmaceutical Equipment Players in 2025
Table 12. World Production-grade Biopharmaceutical Equipment Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Production-grade Biopharmaceutical Equipment Company Evaluation Quadrant
Table 14. Head Office of Key Production-grade Biopharmaceutical Equipment Players
Table 15. Production-grade Biopharmaceutical Equipment Market: Company Product Type Footprint
Table 16. Production-grade Biopharmaceutical Equipment Market: Company Product Application Footprint
Table 17. Production-grade Biopharmaceutical Equipment Mergers & Acquisitions Activity
Table 18. United States VS China Production-grade Biopharmaceutical Equipment Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Production-grade Biopharmaceutical Equipment Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Production-grade Biopharmaceutical Equipment Revenue Market Share (2021-2026)
Table 23. China Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Production-grade Biopharmaceutical Equipment Revenue Market Share (2021-2026)
Table 26. Rest of World Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Production-grade Biopharmaceutical Equipment Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Production-grade Biopharmaceutical Equipment Revenue Market Share (2021-2026)
Table 29. World Production-grade Biopharmaceutical Equipment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Production-grade Biopharmaceutical Equipment Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Production-grade Biopharmaceutical Equipment Market Size by Type (2027-2032) & (USD Million)
Table 32. World Production-grade Biopharmaceutical Equipment Market Size by Process, (USD Million), 2021 & 2025 & 2032
Table 33. World Production-grade Biopharmaceutical Equipment Market Size Value by Process (2021-2026) & (USD Million)
Table 34. World Production-grade Biopharmaceutical Equipment Market Size by Process (2027-2032) & (USD Million)
Table 35. World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity, (USD Million), 2021 & 2025 & 2032
Table 36. World Production-grade Biopharmaceutical Equipment Market Size Value by Bio-fermentation Capacity (2021-2026) & (USD Million)
Table 37. World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity (2027-2032) & (USD Million)
Table 38. World Production-grade Biopharmaceutical Equipment Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Production-grade Biopharmaceutical Equipment Market Size by Application (2021-2026) & (USD Million)
Table 40. World Production-grade Biopharmaceutical Equipment Market Size by Application (2027-2032) & (USD Million)
Table 41. Danaher Basic Information, Manufacturing Base and Competitors
Table 42. Danaher Major Business
Table 43. Danaher Production-grade Biopharmaceutical Equipment Product and Services
Table 44. Danaher Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Danaher Recent Developments/Updates
Table 46. Danaher Competitive Strengths & Weaknesses
Table 47. Sartorius Basic Information, Manufacturing Base and Competitors
Table 48. Sartorius Major Business
Table 49. Sartorius Production-grade Biopharmaceutical Equipment Product and Services
Table 50. Sartorius Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sartorius Recent Developments/Updates
Table 52. Sartorius Competitive Strengths & Weaknesses
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Production-grade Biopharmaceutical Equipment Product and Services
Table 56. Merck KGaA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. Merck KGaA Competitive Strengths & Weaknesses
Table 59. GEA Basic Information, Manufacturing Base and Competitors
Table 60. GEA Major Business
Table 61. GEA Production-grade Biopharmaceutical Equipment Product and Services
Table 62. GEA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. GEA Recent Developments/Updates
Table 64. GEA Competitive Strengths & Weaknesses
Table 65. ALFA LAVAL Basic Information, Manufacturing Base and Competitors
Table 66. ALFA LAVAL Major Business
Table 67. ALFA LAVAL Production-grade Biopharmaceutical Equipment Product and Services
Table 68. ALFA LAVAL Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. ALFA LAVAL Recent Developments/Updates
Table 70. ALFA LAVAL Competitive Strengths & Weaknesses
Table 71. Morimatsu Industry Basic Information, Manufacturing Base and Competitors
Table 72. Morimatsu Industry Major Business
Table 73. Morimatsu Industry Production-grade Biopharmaceutical Equipment Product and Services
Table 74. Morimatsu Industry Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Morimatsu Industry Recent Developments/Updates
Table 76. Morimatsu Industry Competitive Strengths & Weaknesses
Table 77. Sulzer Ltd Basic Information, Manufacturing Base and Competitors
Table 78. Sulzer Ltd Major Business
Table 79. Sulzer Ltd Production-grade Biopharmaceutical Equipment Product and Services
Table 80. Sulzer Ltd Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sulzer Ltd Recent Developments/Updates
Table 82. Sulzer Ltd Competitive Strengths & Weaknesses
Table 83. Tofflon Basic Information, Manufacturing Base and Competitors
Table 84. Tofflon Major Business
Table 85. Tofflon Production-grade Biopharmaceutical Equipment Product and Services
Table 86. Tofflon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Tofflon Recent Developments/Updates
Table 88. Tofflon Competitive Strengths & Weaknesses
Table 89. SPX Flow Basic Information, Manufacturing Base and Competitors
Table 90. SPX Flow Major Business
Table 91. SPX Flow Production-grade Biopharmaceutical Equipment Product and Services
Table 92. SPX Flow Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SPX Flow Recent Developments/Updates
Table 94. SPX Flow Competitive Strengths & Weaknesses
Table 95. Lisure Science Basic Information, Manufacturing Base and Competitors
Table 96. Lisure Science Major Business
Table 97. Lisure Science Production-grade Biopharmaceutical Equipment Product and Services
Table 98. Lisure Science Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lisure Science Recent Developments/Updates
Table 100. Lisure Science Competitive Strengths & Weaknesses
Table 101. AUSTAR Group Basic Information, Manufacturing Base and Competitors
Table 102. AUSTAR Group Major Business
Table 103. AUSTAR Group Production-grade Biopharmaceutical Equipment Product and Services
Table 104. AUSTAR Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AUSTAR Group Recent Developments/Updates
Table 106. AUSTAR Group Competitive Strengths & Weaknesses
Table 107. Truking Technology Basic Information, Manufacturing Base and Competitors
Table 108. Truking Technology Major Business
Table 109. Truking Technology Production-grade Biopharmaceutical Equipment Product and Services
Table 110. Truking Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Truking Technology Recent Developments/Updates
Table 112. Truking Technology Competitive Strengths & Weaknesses
Table 113. Pierre Guerin Basic Information, Manufacturing Base and Competitors
Table 114. Pierre Guerin Major Business
Table 115. Pierre Guerin Production-grade Biopharmaceutical Equipment Product and Services
Table 116. Pierre Guerin Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Pierre Guerin Recent Developments/Updates
Table 118. Pierre Guerin Competitive Strengths & Weaknesses
Table 119. EastBio Basic Information, Manufacturing Base and Competitors
Table 120. EastBio Major Business
Table 121. EastBio Production-grade Biopharmaceutical Equipment Product and Services
Table 122. EastBio Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. EastBio Recent Developments/Updates
Table 124. EastBio Competitive Strengths & Weaknesses
Table 125. Krones AG Basic Information, Manufacturing Base and Competitors
Table 126. Krones AG Major Business
Table 127. Krones AG Production-grade Biopharmaceutical Equipment Product and Services
Table 128. Krones AG Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Krones AG Recent Developments/Updates
Table 130. Krones AG Competitive Strengths & Weaknesses
Table 131. ABEC Basic Information, Manufacturing Base and Competitors
Table 132. ABEC Major Business
Table 133. ABEC Production-grade Biopharmaceutical Equipment Product and Services
Table 134. ABEC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. ABEC Recent Developments/Updates
Table 136. ABEC Competitive Strengths & Weaknesses
Table 137. Flottweg SE Basic Information, Manufacturing Base and Competitors
Table 138. Flottweg SE Major Business
Table 139. Flottweg SE Production-grade Biopharmaceutical Equipment Product and Services
Table 140. Flottweg SE Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Flottweg SE Recent Developments/Updates
Table 142. Flottweg SE Competitive Strengths & Weaknesses
Table 143. Tomoe Basic Information, Manufacturing Base and Competitors
Table 144. Tomoe Major Business
Table 145. Tomoe Production-grade Biopharmaceutical Equipment Product and Services
Table 146. Tomoe Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Tomoe Recent Developments/Updates
Table 148. Tomoe Competitive Strengths & Weaknesses
Table 149. Jiangsu Zhengchang Group Basic Information, Manufacturing Base and Competitors
Table 150. Jiangsu Zhengchang Group Major Business
Table 151. Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Product and Services
Table 152. Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Jiangsu Zhengchang Group Recent Developments/Updates
Table 154. Jiangsu Zhengchang Group Competitive Strengths & Weaknesses
Table 155. DCI, Inc. Basic Information, Manufacturing Base and Competitors
Table 156. DCI, Inc. Major Business
Table 157. DCI, Inc. Production-grade Biopharmaceutical Equipment Product and Services
Table 158. DCI, Inc. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. DCI, Inc. Recent Developments/Updates
Table 160. DCI, Inc. Competitive Strengths & Weaknesses
Table 161. Greatwall Mixers Basic Information, Manufacturing Base and Competitors
Table 162. Greatwall Mixers Major Business
Table 163. Greatwall Mixers Production-grade Biopharmaceutical Equipment Product and Services
Table 164. Greatwall Mixers Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Greatwall Mixers Recent Developments/Updates
Table 166. Greatwall Mixers Competitive Strengths & Weaknesses
Table 167. EKATO Basic Information, Manufacturing Base and Competitors
Table 168. EKATO Major Business
Table 169. EKATO Production-grade Biopharmaceutical Equipment Product and Services
Table 170. EKATO Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. EKATO Recent Developments/Updates
Table 172. EKATO Competitive Strengths & Weaknesses
Table 173. Jiangsu Hanbon Basic Information, Manufacturing Base and Competitors
Table 174. Jiangsu Hanbon Major Business
Table 175. Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Product and Services
Table 176. Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Jiangsu Hanbon Recent Developments/Updates
Table 178. Jiangsu Hanbon Competitive Strengths & Weaknesses
Table 179. Cotter Brothers Corporation Basic Information, Manufacturing Base and Competitors
Table 180. Cotter Brothers Corporation Major Business
Table 181. Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Product and Services
Table 182. Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Cotter Brothers Corporation Recent Developments/Updates
Table 184. Cotter Brothers Corporation Competitive Strengths & Weaknesses
Table 185. Holloway America Basic Information, Manufacturing Base and Competitors
Table 186. Holloway America Major Business
Table 187. Holloway America Production-grade Biopharmaceutical Equipment Product and Services
Table 188. Holloway America Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Holloway America Recent Developments/Updates
Table 190. Holloway America Competitive Strengths & Weaknesses
Table 191. BHS-Sonthofen GmbH Basic Information, Manufacturing Base and Competitors
Table 192. BHS-Sonthofen GmbH Major Business
Table 193. BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Product and Services
Table 194. BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. BHS-Sonthofen GmbH Recent Developments/Updates
Table 196. BHS-Sonthofen GmbH Competitive Strengths & Weaknesses
Table 197. Actini Group Basic Information, Manufacturing Base and Competitors
Table 198. Actini Group Major Business
Table 199. Actini Group Production-grade Biopharmaceutical Equipment Product and Services
Table 200. Actini Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Actini Group Recent Developments/Updates
Table 202. Actini Group Competitive Strengths & Weaknesses
Table 203. Shanghai Triowin Intelligent Machinery Basic Information, Manufacturing Base and Competitors
Table 204. Shanghai Triowin Intelligent Machinery Major Business
Table 205. Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Product and Services
Table 206. Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Shanghai Triowin Intelligent Machinery Recent Developments/Updates
Table 208. Shanghai Triowin Intelligent Machinery Competitive Strengths & Weaknesses
Table 209. YMC CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 210. YMC CO., LTD. Major Business
Table 211. YMC CO., LTD. Production-grade Biopharmaceutical Equipment Product and Services
Table 212. YMC CO., LTD. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. YMC CO., LTD. Recent Developments/Updates
Table 214. YMC CO., LTD. Competitive Strengths & Weaknesses
Table 215. Ohkawara Kakohki Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 216. Ohkawara Kakohki Co., Ltd. Major Business
Table 217. Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Product and Services
Table 218. Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Ohkawara Kakohki Co., Ltd. Recent Developments/Updates
Table 220. Ohkawara Kakohki Co., Ltd. Competitive Strengths & Weaknesses
Table 221. Suntar Environmental Technology Basic Information, Manufacturing Base and Competitors
Table 222. Suntar Environmental Technology Major Business
Table 223. Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Product and Services
Table 224. Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Suntar Environmental Technology Recent Developments/Updates
Table 226. Suntar Environmental Technology Competitive Strengths & Weaknesses
Table 227. Buss-SMS-Canzler GmbH Basic Information, Manufacturing Base and Competitors
Table 228. Buss-SMS-Canzler GmbH Major Business
Table 229. Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Product and Services
Table 230. Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Buss-SMS-Canzler GmbH Recent Developments/Updates
Table 232. Buss-SMS-Canzler GmbH Competitive Strengths & Weaknesses
Table 233. TECNIC Basic Information, Manufacturing Base and Competitors
Table 234. TECNIC Major Business
Table 235. TECNIC Production-grade Biopharmaceutical Equipment Product and Services
Table 236. TECNIC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. TECNIC Recent Developments/Updates
Table 238. TECNIC Competitive Strengths & Weaknesses
Table 239. Jiangsu Jiuwu Hi-Tech Basic Information, Manufacturing Base and Competitors
Table 240. Jiangsu Jiuwu Hi-Tech Major Business
Table 241. Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Product and Services
Table 242. Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Jiangsu Jiuwu Hi-Tech Recent Developments/Updates
Table 244. Jiangsu Jiuwu Hi-Tech Competitive Strengths & Weaknesses
Table 245. Hengfengtai Basic Information, Manufacturing Base and Competitors
Table 246. Hengfengtai Major Business
Table 247. Hengfengtai Production-grade Biopharmaceutical Equipment Product and Services
Table 248. Hengfengtai Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Hengfengtai Recent Developments/Updates
Table 250. Hengfengtai Competitive Strengths & Weaknesses
Table 251. Beijing ChuangXinTongHeng Basic Information, Manufacturing Base and Competitors
Table 252. Beijing ChuangXinTongHeng Major Business
Table 253. Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Product and Services
Table 254. Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Beijing ChuangXinTongHeng Recent Developments/Updates
Table 256. Beijing ChuangXinTongHeng Competitive Strengths & Weaknesses
Table 257. BIIC Bianchi SpA Basic Information, Manufacturing Base and Competitors
Table 258. BIIC Bianchi SpA Major Business
Table 259. BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Product and Services
Table 260. BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. BIIC Bianchi SpA Recent Developments/Updates
Table 262. BIIC Bianchi SpA Competitive Strengths & Weaknesses
Table 263. Alsys Group Basic Information, Manufacturing Base and Competitors
Table 264. Alsys Group Major Business
Table 265. Alsys Group Production-grade Biopharmaceutical Equipment Product and Services
Table 266. Alsys Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Alsys Group Recent Developments/Updates
Table 268. Alsys Group Competitive Strengths & Weaknesses
Table 269. Solaris Biotech Basic Information, Manufacturing Base and Competitors
Table 270. Solaris Biotech Major Business
Table 271. Solaris Biotech Production-grade Biopharmaceutical Equipment Product and Services
Table 272. Solaris Biotech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Solaris Biotech Recent Developments/Updates
Table 274. Solaris Biotech Competitive Strengths & Weaknesses
Table 275. Global Key Players of Production-grade Biopharmaceutical Equipment Upstream (Raw Materials)
Table 276. Global Production-grade Biopharmaceutical Equipment Typical Customers
Table 1. World Production-grade Biopharmaceutical Equipment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Production-grade Biopharmaceutical Equipment Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Production-grade Biopharmaceutical Equipment Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Production-grade Biopharmaceutical Equipment Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Production-grade Biopharmaceutical Equipment Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Production-grade Biopharmaceutical Equipment Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Production-grade Biopharmaceutical Equipment Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Production-grade Biopharmaceutical Equipment Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Production-grade Biopharmaceutical Equipment Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Production-grade Biopharmaceutical Equipment Players in 2025
Table 12. World Production-grade Biopharmaceutical Equipment Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Production-grade Biopharmaceutical Equipment Company Evaluation Quadrant
Table 14. Head Office of Key Production-grade Biopharmaceutical Equipment Players
Table 15. Production-grade Biopharmaceutical Equipment Market: Company Product Type Footprint
Table 16. Production-grade Biopharmaceutical Equipment Market: Company Product Application Footprint
Table 17. Production-grade Biopharmaceutical Equipment Mergers & Acquisitions Activity
Table 18. United States VS China Production-grade Biopharmaceutical Equipment Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Production-grade Biopharmaceutical Equipment Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (States, Country)
Table 21. United States Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Production-grade Biopharmaceutical Equipment Revenue Market Share (2021-2026)
Table 23. China Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (Province, Country)
Table 24. China Based Companies Production-grade Biopharmaceutical Equipment Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Production-grade Biopharmaceutical Equipment Revenue Market Share (2021-2026)
Table 26. Rest of World Based Production-grade Biopharmaceutical Equipment Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Production-grade Biopharmaceutical Equipment Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Production-grade Biopharmaceutical Equipment Revenue Market Share (2021-2026)
Table 29. World Production-grade Biopharmaceutical Equipment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Production-grade Biopharmaceutical Equipment Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Production-grade Biopharmaceutical Equipment Market Size by Type (2027-2032) & (USD Million)
Table 32. World Production-grade Biopharmaceutical Equipment Market Size by Process, (USD Million), 2021 & 2025 & 2032
Table 33. World Production-grade Biopharmaceutical Equipment Market Size Value by Process (2021-2026) & (USD Million)
Table 34. World Production-grade Biopharmaceutical Equipment Market Size by Process (2027-2032) & (USD Million)
Table 35. World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity, (USD Million), 2021 & 2025 & 2032
Table 36. World Production-grade Biopharmaceutical Equipment Market Size Value by Bio-fermentation Capacity (2021-2026) & (USD Million)
Table 37. World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity (2027-2032) & (USD Million)
Table 38. World Production-grade Biopharmaceutical Equipment Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Production-grade Biopharmaceutical Equipment Market Size by Application (2021-2026) & (USD Million)
Table 40. World Production-grade Biopharmaceutical Equipment Market Size by Application (2027-2032) & (USD Million)
Table 41. Danaher Basic Information, Manufacturing Base and Competitors
Table 42. Danaher Major Business
Table 43. Danaher Production-grade Biopharmaceutical Equipment Product and Services
Table 44. Danaher Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Danaher Recent Developments/Updates
Table 46. Danaher Competitive Strengths & Weaknesses
Table 47. Sartorius Basic Information, Manufacturing Base and Competitors
Table 48. Sartorius Major Business
Table 49. Sartorius Production-grade Biopharmaceutical Equipment Product and Services
Table 50. Sartorius Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Sartorius Recent Developments/Updates
Table 52. Sartorius Competitive Strengths & Weaknesses
Table 53. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 54. Merck KGaA Major Business
Table 55. Merck KGaA Production-grade Biopharmaceutical Equipment Product and Services
Table 56. Merck KGaA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Merck KGaA Recent Developments/Updates
Table 58. Merck KGaA Competitive Strengths & Weaknesses
Table 59. GEA Basic Information, Manufacturing Base and Competitors
Table 60. GEA Major Business
Table 61. GEA Production-grade Biopharmaceutical Equipment Product and Services
Table 62. GEA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. GEA Recent Developments/Updates
Table 64. GEA Competitive Strengths & Weaknesses
Table 65. ALFA LAVAL Basic Information, Manufacturing Base and Competitors
Table 66. ALFA LAVAL Major Business
Table 67. ALFA LAVAL Production-grade Biopharmaceutical Equipment Product and Services
Table 68. ALFA LAVAL Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. ALFA LAVAL Recent Developments/Updates
Table 70. ALFA LAVAL Competitive Strengths & Weaknesses
Table 71. Morimatsu Industry Basic Information, Manufacturing Base and Competitors
Table 72. Morimatsu Industry Major Business
Table 73. Morimatsu Industry Production-grade Biopharmaceutical Equipment Product and Services
Table 74. Morimatsu Industry Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Morimatsu Industry Recent Developments/Updates
Table 76. Morimatsu Industry Competitive Strengths & Weaknesses
Table 77. Sulzer Ltd Basic Information, Manufacturing Base and Competitors
Table 78. Sulzer Ltd Major Business
Table 79. Sulzer Ltd Production-grade Biopharmaceutical Equipment Product and Services
Table 80. Sulzer Ltd Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sulzer Ltd Recent Developments/Updates
Table 82. Sulzer Ltd Competitive Strengths & Weaknesses
Table 83. Tofflon Basic Information, Manufacturing Base and Competitors
Table 84. Tofflon Major Business
Table 85. Tofflon Production-grade Biopharmaceutical Equipment Product and Services
Table 86. Tofflon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Tofflon Recent Developments/Updates
Table 88. Tofflon Competitive Strengths & Weaknesses
Table 89. SPX Flow Basic Information, Manufacturing Base and Competitors
Table 90. SPX Flow Major Business
Table 91. SPX Flow Production-grade Biopharmaceutical Equipment Product and Services
Table 92. SPX Flow Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. SPX Flow Recent Developments/Updates
Table 94. SPX Flow Competitive Strengths & Weaknesses
Table 95. Lisure Science Basic Information, Manufacturing Base and Competitors
Table 96. Lisure Science Major Business
Table 97. Lisure Science Production-grade Biopharmaceutical Equipment Product and Services
Table 98. Lisure Science Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Lisure Science Recent Developments/Updates
Table 100. Lisure Science Competitive Strengths & Weaknesses
Table 101. AUSTAR Group Basic Information, Manufacturing Base and Competitors
Table 102. AUSTAR Group Major Business
Table 103. AUSTAR Group Production-grade Biopharmaceutical Equipment Product and Services
Table 104. AUSTAR Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AUSTAR Group Recent Developments/Updates
Table 106. AUSTAR Group Competitive Strengths & Weaknesses
Table 107. Truking Technology Basic Information, Manufacturing Base and Competitors
Table 108. Truking Technology Major Business
Table 109. Truking Technology Production-grade Biopharmaceutical Equipment Product and Services
Table 110. Truking Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Truking Technology Recent Developments/Updates
Table 112. Truking Technology Competitive Strengths & Weaknesses
Table 113. Pierre Guerin Basic Information, Manufacturing Base and Competitors
Table 114. Pierre Guerin Major Business
Table 115. Pierre Guerin Production-grade Biopharmaceutical Equipment Product and Services
Table 116. Pierre Guerin Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Pierre Guerin Recent Developments/Updates
Table 118. Pierre Guerin Competitive Strengths & Weaknesses
Table 119. EastBio Basic Information, Manufacturing Base and Competitors
Table 120. EastBio Major Business
Table 121. EastBio Production-grade Biopharmaceutical Equipment Product and Services
Table 122. EastBio Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. EastBio Recent Developments/Updates
Table 124. EastBio Competitive Strengths & Weaknesses
Table 125. Krones AG Basic Information, Manufacturing Base and Competitors
Table 126. Krones AG Major Business
Table 127. Krones AG Production-grade Biopharmaceutical Equipment Product and Services
Table 128. Krones AG Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Krones AG Recent Developments/Updates
Table 130. Krones AG Competitive Strengths & Weaknesses
Table 131. ABEC Basic Information, Manufacturing Base and Competitors
Table 132. ABEC Major Business
Table 133. ABEC Production-grade Biopharmaceutical Equipment Product and Services
Table 134. ABEC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. ABEC Recent Developments/Updates
Table 136. ABEC Competitive Strengths & Weaknesses
Table 137. Flottweg SE Basic Information, Manufacturing Base and Competitors
Table 138. Flottweg SE Major Business
Table 139. Flottweg SE Production-grade Biopharmaceutical Equipment Product and Services
Table 140. Flottweg SE Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Flottweg SE Recent Developments/Updates
Table 142. Flottweg SE Competitive Strengths & Weaknesses
Table 143. Tomoe Basic Information, Manufacturing Base and Competitors
Table 144. Tomoe Major Business
Table 145. Tomoe Production-grade Biopharmaceutical Equipment Product and Services
Table 146. Tomoe Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Tomoe Recent Developments/Updates
Table 148. Tomoe Competitive Strengths & Weaknesses
Table 149. Jiangsu Zhengchang Group Basic Information, Manufacturing Base and Competitors
Table 150. Jiangsu Zhengchang Group Major Business
Table 151. Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Product and Services
Table 152. Jiangsu Zhengchang Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Jiangsu Zhengchang Group Recent Developments/Updates
Table 154. Jiangsu Zhengchang Group Competitive Strengths & Weaknesses
Table 155. DCI, Inc. Basic Information, Manufacturing Base and Competitors
Table 156. DCI, Inc. Major Business
Table 157. DCI, Inc. Production-grade Biopharmaceutical Equipment Product and Services
Table 158. DCI, Inc. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. DCI, Inc. Recent Developments/Updates
Table 160. DCI, Inc. Competitive Strengths & Weaknesses
Table 161. Greatwall Mixers Basic Information, Manufacturing Base and Competitors
Table 162. Greatwall Mixers Major Business
Table 163. Greatwall Mixers Production-grade Biopharmaceutical Equipment Product and Services
Table 164. Greatwall Mixers Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Greatwall Mixers Recent Developments/Updates
Table 166. Greatwall Mixers Competitive Strengths & Weaknesses
Table 167. EKATO Basic Information, Manufacturing Base and Competitors
Table 168. EKATO Major Business
Table 169. EKATO Production-grade Biopharmaceutical Equipment Product and Services
Table 170. EKATO Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. EKATO Recent Developments/Updates
Table 172. EKATO Competitive Strengths & Weaknesses
Table 173. Jiangsu Hanbon Basic Information, Manufacturing Base and Competitors
Table 174. Jiangsu Hanbon Major Business
Table 175. Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Product and Services
Table 176. Jiangsu Hanbon Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. Jiangsu Hanbon Recent Developments/Updates
Table 178. Jiangsu Hanbon Competitive Strengths & Weaknesses
Table 179. Cotter Brothers Corporation Basic Information, Manufacturing Base and Competitors
Table 180. Cotter Brothers Corporation Major Business
Table 181. Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Product and Services
Table 182. Cotter Brothers Corporation Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. Cotter Brothers Corporation Recent Developments/Updates
Table 184. Cotter Brothers Corporation Competitive Strengths & Weaknesses
Table 185. Holloway America Basic Information, Manufacturing Base and Competitors
Table 186. Holloway America Major Business
Table 187. Holloway America Production-grade Biopharmaceutical Equipment Product and Services
Table 188. Holloway America Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 189. Holloway America Recent Developments/Updates
Table 190. Holloway America Competitive Strengths & Weaknesses
Table 191. BHS-Sonthofen GmbH Basic Information, Manufacturing Base and Competitors
Table 192. BHS-Sonthofen GmbH Major Business
Table 193. BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Product and Services
Table 194. BHS-Sonthofen GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 195. BHS-Sonthofen GmbH Recent Developments/Updates
Table 196. BHS-Sonthofen GmbH Competitive Strengths & Weaknesses
Table 197. Actini Group Basic Information, Manufacturing Base and Competitors
Table 198. Actini Group Major Business
Table 199. Actini Group Production-grade Biopharmaceutical Equipment Product and Services
Table 200. Actini Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 201. Actini Group Recent Developments/Updates
Table 202. Actini Group Competitive Strengths & Weaknesses
Table 203. Shanghai Triowin Intelligent Machinery Basic Information, Manufacturing Base and Competitors
Table 204. Shanghai Triowin Intelligent Machinery Major Business
Table 205. Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Product and Services
Table 206. Shanghai Triowin Intelligent Machinery Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 207. Shanghai Triowin Intelligent Machinery Recent Developments/Updates
Table 208. Shanghai Triowin Intelligent Machinery Competitive Strengths & Weaknesses
Table 209. YMC CO., LTD. Basic Information, Manufacturing Base and Competitors
Table 210. YMC CO., LTD. Major Business
Table 211. YMC CO., LTD. Production-grade Biopharmaceutical Equipment Product and Services
Table 212. YMC CO., LTD. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 213. YMC CO., LTD. Recent Developments/Updates
Table 214. YMC CO., LTD. Competitive Strengths & Weaknesses
Table 215. Ohkawara Kakohki Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 216. Ohkawara Kakohki Co., Ltd. Major Business
Table 217. Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Product and Services
Table 218. Ohkawara Kakohki Co., Ltd. Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 219. Ohkawara Kakohki Co., Ltd. Recent Developments/Updates
Table 220. Ohkawara Kakohki Co., Ltd. Competitive Strengths & Weaknesses
Table 221. Suntar Environmental Technology Basic Information, Manufacturing Base and Competitors
Table 222. Suntar Environmental Technology Major Business
Table 223. Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Product and Services
Table 224. Suntar Environmental Technology Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 225. Suntar Environmental Technology Recent Developments/Updates
Table 226. Suntar Environmental Technology Competitive Strengths & Weaknesses
Table 227. Buss-SMS-Canzler GmbH Basic Information, Manufacturing Base and Competitors
Table 228. Buss-SMS-Canzler GmbH Major Business
Table 229. Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Product and Services
Table 230. Buss-SMS-Canzler GmbH Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 231. Buss-SMS-Canzler GmbH Recent Developments/Updates
Table 232. Buss-SMS-Canzler GmbH Competitive Strengths & Weaknesses
Table 233. TECNIC Basic Information, Manufacturing Base and Competitors
Table 234. TECNIC Major Business
Table 235. TECNIC Production-grade Biopharmaceutical Equipment Product and Services
Table 236. TECNIC Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 237. TECNIC Recent Developments/Updates
Table 238. TECNIC Competitive Strengths & Weaknesses
Table 239. Jiangsu Jiuwu Hi-Tech Basic Information, Manufacturing Base and Competitors
Table 240. Jiangsu Jiuwu Hi-Tech Major Business
Table 241. Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Product and Services
Table 242. Jiangsu Jiuwu Hi-Tech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 243. Jiangsu Jiuwu Hi-Tech Recent Developments/Updates
Table 244. Jiangsu Jiuwu Hi-Tech Competitive Strengths & Weaknesses
Table 245. Hengfengtai Basic Information, Manufacturing Base and Competitors
Table 246. Hengfengtai Major Business
Table 247. Hengfengtai Production-grade Biopharmaceutical Equipment Product and Services
Table 248. Hengfengtai Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 249. Hengfengtai Recent Developments/Updates
Table 250. Hengfengtai Competitive Strengths & Weaknesses
Table 251. Beijing ChuangXinTongHeng Basic Information, Manufacturing Base and Competitors
Table 252. Beijing ChuangXinTongHeng Major Business
Table 253. Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Product and Services
Table 254. Beijing ChuangXinTongHeng Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 255. Beijing ChuangXinTongHeng Recent Developments/Updates
Table 256. Beijing ChuangXinTongHeng Competitive Strengths & Weaknesses
Table 257. BIIC Bianchi SpA Basic Information, Manufacturing Base and Competitors
Table 258. BIIC Bianchi SpA Major Business
Table 259. BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Product and Services
Table 260. BIIC Bianchi SpA Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 261. BIIC Bianchi SpA Recent Developments/Updates
Table 262. BIIC Bianchi SpA Competitive Strengths & Weaknesses
Table 263. Alsys Group Basic Information, Manufacturing Base and Competitors
Table 264. Alsys Group Major Business
Table 265. Alsys Group Production-grade Biopharmaceutical Equipment Product and Services
Table 266. Alsys Group Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 267. Alsys Group Recent Developments/Updates
Table 268. Alsys Group Competitive Strengths & Weaknesses
Table 269. Solaris Biotech Basic Information, Manufacturing Base and Competitors
Table 270. Solaris Biotech Major Business
Table 271. Solaris Biotech Production-grade Biopharmaceutical Equipment Product and Services
Table 272. Solaris Biotech Production-grade Biopharmaceutical Equipment Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 273. Solaris Biotech Recent Developments/Updates
Table 274. Solaris Biotech Competitive Strengths & Weaknesses
Table 275. Global Key Players of Production-grade Biopharmaceutical Equipment Upstream (Raw Materials)
Table 276. Global Production-grade Biopharmaceutical Equipment Typical Customers
LIST OF FIGURES
Figure 1. Production-grade Biopharmaceutical Equipment Picture
Figure 2. World Production-grade Biopharmaceutical Equipment Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Production-grade Biopharmaceutical Equipment Total Revenue (2021-2032) & (USD Million)
Figure 4. World Production-grade Biopharmaceutical Equipment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Production-grade Biopharmaceutical Equipment Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 13. Production-grade Biopharmaceutical Equipment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 16. World Production-grade Biopharmaceutical Equipment Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 18. China Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 23. India Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Production-grade Biopharmaceutical Equipment by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Production-grade Biopharmaceutical Equipment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Production-grade Biopharmaceutical Equipment Markets in 2025
Figure 27. United States VS China: Production-grade Biopharmaceutical Equipment Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Production-grade Biopharmaceutical Equipment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Production-grade Biopharmaceutical Equipment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Type in 2025
Figure 31. Raw Material Handling and Preparation Equipment
Figure 32. Material Conveying Equipment
Figure 33. Air Supply Engineering Equipment
Figure 34. Bioreactors and Fermenters
Figure 35. Separation and Purification Equipment
Figure 36. Evaporation and Crystallization Equipment
Figure 37. Drying Equipment
Figure 38. Cleaning Equipment
Figure 39. Drying Equipment
Figure 40. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Type (2021-2032)
Figure 41. World Production-grade Biopharmaceutical Equipment Market Size by Process, (USD Million), 2021 & 2025 & 2032
Figure 42. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Process in 2025
Figure 43. Based on Single-use Process
Figure 44. Based on Reusable Process
Figure 45. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Process (2021-2032)
Figure 46. World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity, (USD Million), 2021 & 2025 & 2032
Figure 47. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Bio-fermentation Capacity in 2025
Figure 48. ?2000L
Figure 49. 2000-5000L
Figure 50. ?5000L
Figure 51. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Bio-fermentation Capacity (2021-2032)
Figure 52. World Production-grade Biopharmaceutical Equipment Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Application in 2025
Figure 54. Macromolecular Biopharmaceuticals
Figure 55. Small Molecule Chemical Drugs
Figure 56. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Application (2021-2032)
Figure 57. Production-grade Biopharmaceutical Equipment Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Production-grade Biopharmaceutical Equipment Picture
Figure 2. World Production-grade Biopharmaceutical Equipment Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Production-grade Biopharmaceutical Equipment Total Revenue (2021-2032) & (USD Million)
Figure 4. World Production-grade Biopharmaceutical Equipment Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Production-grade Biopharmaceutical Equipment Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Production-grade Biopharmaceutical Equipment Revenue (2021-2032) & (USD Million)
Figure 13. Production-grade Biopharmaceutical Equipment Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 16. World Production-grade Biopharmaceutical Equipment Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 18. China Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 23. India Production-grade Biopharmaceutical Equipment Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Production-grade Biopharmaceutical Equipment by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Production-grade Biopharmaceutical Equipment Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Production-grade Biopharmaceutical Equipment Markets in 2025
Figure 27. United States VS China: Production-grade Biopharmaceutical Equipment Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Production-grade Biopharmaceutical Equipment Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Production-grade Biopharmaceutical Equipment Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Type in 2025
Figure 31. Raw Material Handling and Preparation Equipment
Figure 32. Material Conveying Equipment
Figure 33. Air Supply Engineering Equipment
Figure 34. Bioreactors and Fermenters
Figure 35. Separation and Purification Equipment
Figure 36. Evaporation and Crystallization Equipment
Figure 37. Drying Equipment
Figure 38. Cleaning Equipment
Figure 39. Drying Equipment
Figure 40. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Type (2021-2032)
Figure 41. World Production-grade Biopharmaceutical Equipment Market Size by Process, (USD Million), 2021 & 2025 & 2032
Figure 42. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Process in 2025
Figure 43. Based on Single-use Process
Figure 44. Based on Reusable Process
Figure 45. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Process (2021-2032)
Figure 46. World Production-grade Biopharmaceutical Equipment Market Size by Bio-fermentation Capacity, (USD Million), 2021 & 2025 & 2032
Figure 47. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Bio-fermentation Capacity in 2025
Figure 48. ?2000L
Figure 49. 2000-5000L
Figure 50. ?5000L
Figure 51. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Bio-fermentation Capacity (2021-2032)
Figure 52. World Production-grade Biopharmaceutical Equipment Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 53. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Application in 2025
Figure 54. Macromolecular Biopharmaceuticals
Figure 55. Small Molecule Chemical Drugs
Figure 56. World Production-grade Biopharmaceutical Equipment Market Size Market Share by Application (2021-2032)
Figure 57. Production-grade Biopharmaceutical Equipment Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
